HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): George J. Magovern, Jr. Vincent L. Gott Timothy J. Gardner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Magovern, G. J. Articles by Gardner, T. J. Search for Related Content PubMed PubMed Citation Articles by Magovern, G. J., Jr. Articles by Gardner, T. J.

Ann Thorac Surg 1982;34:249-257
© 1982 The Society of Thoracic Surgeons

---

Articles

Optimal Myocardial Protection with Fluosol Cardioplegia

From the Divisions of Cardiac Surgery and Cardiology, The Johns Hopkins Medical Institutions, Baltimore, MD

^* Address correspondence to Dr. Gardner, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD 21205

An oxygenated perfluorocarbon cardioplegic solution was examined, utilizing a blood-perfused canine model. Twenty-one animals were divided into three equal groups, and each animal received Fluosol cardioplegia at one of three infusion temperatures: 20°C, 10°C, or 4°C. All hearts underwent 90 minutes of ischemia, during which time 150 ml of the cardioplegic solution was infused every 30 minutes. Myocardial oxygen and carbon dioxide tensions (PmO₂ and PmCO₂) were monitored continually using mass spectrometry, and myocardial oxygen consumption was calculated with each cardioplegic injection.

The mean increase in PmO₂ was 7.1 ± 0.9 mm Hg with 20°C Fluosol infusions, 31.1 ± 4.7 mm Hg with 10°C Fluosol injections, and 22.2 ± 4.7 mm Hg with infusions of 4°C Fluosol. Average myocardial oxygen consumption, expressed as cubic centimeters of oxygen per 100 gm of left ventricle (wet weight), was 21.2 ± 0.5 with 20°C Fluosol, 22.8 ± 1.3 for 10°C Fluosol, and 19.6 ± 1.0 for 4°C Fluosol. Mean myocardial temperatures with infusions of 20°C, 10°C, and 4°C solutions were 21.4 ± 0.1°C, 16.9 ± 0.4°C, and 15.9 ± 0.5°C, respectively. After 45 minutes of reperfusion, maximum rate of rise of left ventricular pressure, expressed as percentage of preischemic control, was 70.9 ± 3.9% for 20°C Fluosol, 90.9 ± 3.2% for 10°C Fluosol, and 90.4 ± 2.3% for 4°C Fluosol (p < 0.005, 20°C versus 10°C, 4°C Fluosol). In addition, the 10°C and 4°C Fluosol hearts had essentially normal structure by light and electron microscopy. These data demonstrate that Fluosol cardioplegia results in near optimal myocardial protection when infused at cold temperatures (4°C to 10°C). The increases in intramyocardial oxygen and myocardial oxygen consumption with each injection demonstrate that there is enhanced oxygen delivery and utilization, which may account for the improved functional recovery observed in these hearts.

This article has been cited by other articles:

				A. Marchbank Fluorocarbon emulsions Perfusion, March 1, 1995; 10(2): 67 - 88. [PDF]

				W. L. Holman, W. V. A. Vicente, R. D. Spruell, S. B. Digerness, and A. D. Pacifico Effect of hemoglobin concentration on oxyhemoglobin dissociation during hypothermic blood cardioplegic arrest J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 664 - 671. [Abstract] [Full Text]

				S. Levitsky Myocardial Protection Ann. Thorac. Surg., September 1, 1987; 44(3): 328 - 329. [PDF]

				F. Oguma, S. Imai, and S. Eguchi Role Played by Oxygen in Myocardial Protection with Crystalloid Cardioplegic Solution Ann. Thorac. Surg., August 1, 1986; 42(2): 172 - 179. [Abstract] [PDF]

				P. Menasche, E. Pinard, A.-M. Desroches, J. Seylaz, P. Laget, R. P. Geyer, and A. Piwnica Fluorocarbons: A Potential Treatment of Cerebral Air Embolism in Open-Heart Surgery Ann. Thorac. Surg., November 1, 1985; 40(5): 494 - 497. [Abstract] [PDF]